Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited)

v3.25.1
Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance, amount at Dec. 31, 2023 $ (18,243,421) $ 24,846 $ 18,972,901 $ (37,124,126) $ (117,042)
Beginning balance, shares at Dec. 31, 2023   24,845,439      
Net income (loss) 208,908     208,908  
Foreign currency translation gain (loss) (30,394)       (30,394)
Stock options exercised 24,200 $ 20 24,180    
Stock options exercised, share   20,000      
Stock-based compensation 141,242 $ 45 141,197    
Stock-based compensation, share   45,243      
Ending balance, amount at Mar. 31, 2024 (17,899,465) $ 24,911 19,138,278 (36,915,218) (147,436)
Ending balance, shares at Mar. 31, 2024   24,910,682      
Beginning balance, amount at Dec. 31, 2024 (20,054,339) $ 25,115 19,948,363 (39,751,236) (276,581)
Beginning balance, shares at Dec. 31, 2024   25,115,299      
Net income (loss) (2,021,282)     (2,021,282)  
Foreign currency translation gain (loss) 151,790       151,790
Stock options exercised 127,000 $ 100 126,900    
Stock options exercised, share   100,000      
Stock-based compensation 166,261 $ 38 166,223    
Stock-based compensation, share   38,216      
Ending balance, amount at Mar. 31, 2025 $ (21,630,570) $ 25,253 $ 20,241,486 $ (41,772,518) $ (124,791)
Ending balance, shares at Mar. 31, 2025   25,253,515